• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513740
Device Problems Failure to Advance (2524); Activation, Positioning or Separation Problem (2906); Material Deformation (2976); Material Twisted/Bent (2981)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/13/2022
Event Type  malfunction  
Manufacturer Narrative
Initial reporter's address1: (b)(6).
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2022, that an ultraflex esophageal ng distal release stent was to be implanted to treat an 8 cm malignant esophageal stricture during an esophageal stent placement procedure performed on (b)(6) 2022.The patient anatomy was tortuous and was dilated prior to stent placement.During the procedure, the stent delivery system had difficulty crossing the stricture, and the delivery shaft got bent.The black stent deployment suture became stuck, and the stent could not be deployed.The ultrafex esophageal stent was removed from the patient partially deployed on the delivery system.The procedure was complete with a different device.There were no patient complications reported as a result of this event.The patient condition at the conclusion of the procedure was reported to be fine.
 
Manufacturer Narrative
E1: (b)(6).H6: imdrf device code a15 captures the reportable event of ultraflex esophageal stent partially deployed.H10: an ultraflex esophageal distal covered stent and delivery system were received for analysis.The stent was received partially deployed.Visual inspection found the shaft slightly bent.The deployment suture was inspected and no problems or knots were noted.The outer diameter of the stent was measured and found to be within specification.Functional inspection revealed that it was possible to deploy the stent by holding the handle hub in the palm of one hand, grasping and retracting the finger ring with the other hand.No other problems were noted to the stent and delivery system.Product analysis confirmed the reported events of stent partially deployed and shaft bent; however, the reported event of stent deployment suture knotted was not confirmed as no problems were noted during visual inspection.The reported event of delivery system difficult to cross lesion could not be confirmed as this occurred during the procedure and is not possible to replicate in the laboratory of analysis.It may be that the patient's tortuous anatomy contributed to the difficulty in crossing the stricture and the shaft being bent which then resulted to the stent being partially deployed.Therefore, a review and analysis of all available information indicated the most probable cause is adverse event related to patient condition.A product labeling review identified that the device was used per the instructions for use (ifu) / product label.
 
Event Description
It was reported to boston scientific corporation on december 13, 2022, that an ultraflex esophageal ng distal release stent was to be implanted to treat an 8 cm malignant esophageal stricture during an esophageal stent placement procedure performed on (b)(6) 2022.The patient anatomy was tortuous and was dilated prior to stent placement.During the procedure, the stent delivery system had difficulty crossing the stricture, and the delivery shaft got bent.The black stent deployment suture became stuck, and the stent could not be deployed.The ultrafex esophageal stent was removed from the patient partially deployed on the delivery system.The procedure was complete with a different device.There were no patient complications reported as a result of this event.The patient condition at the conclusion of the procedure was reported to be fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16090642
MDR Text Key306845758
Report Number3005099803-2022-07866
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716167
UDI-Public08714729716167
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 06/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2023
Device Model NumberM00513740
Device Catalogue Number1374
Device Lot Number0028468771
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/13/2022
Initial Date FDA Received01/03/2023
Supplement Dates Manufacturer Received05/18/2023
Supplement Dates FDA Received06/06/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/30/2021
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age76 YR
Patient SexMale
-
-